Nanobiotix develops nanoparticle medicines, led by a candidate designed to boost the effect of radiotherapy on cancer tumors. It last closed at $26.50 on Nov 20, down 2.98% on the day.
AI Auto Pilots
Is NBTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NBTX.
From NBTX's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 31). Last 12 months adds up the four latest quarters. Figures are in EUR. Per share figures are left out because the US listing can represent a different number of shares.
NBTX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 15% below its 20 day and 11% below its 50 day average. It is 30% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 40). The nearest support is the Pivot S1 at $25.55, and the nearest resistance the Pivot at $27.07.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 8.9%/day
Key levels
$57.1452 week high+115.6%
$34.77Swing high (Oct 27)+31.2%
$34.49100 day average+30.2%
$34.47200 day average+30.1%
$30.4820 day average+15.0%
$29.3150 day average+10.6%
$28.03Pivot R1+5.8%
$27.07Pivot+2.2%
$26.50Last close
$25.55Pivot S1−3.6%
$20.70Swing low (Oct 19)−21.9%
$19.1452 week low−27.8%
Indicators
RSI (14)
40.16
Middle of its range
Neutral
MACD
-0.45
Below its signal line
Bearish
Stochastic
6.8
Near the bottom of its range
Oversold
ADX (14)
17.3
No clear trend
Williams %R
-95.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-126.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−13.5%
Change over 10 sessions
Bearish
ATR (14)
$2.37
Typical daily range, 8.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 20.9%/day
Key levels
$57.1452 week high+115.6%
$34.77Swing high (Oct 27)+31.2%
$34.49100 day average+30.2%
$34.47200 day average+30.1%
$30.4820 day average+15.0%
$29.3150 day average+10.6%
$28.03Pivot R1+5.8%
$27.07Pivot+2.2%
$26.50Last close
$25.55Pivot S1−3.6%
$20.70Swing low (Oct 19)−21.9%
$19.1452 week low−27.8%
Indicators
RSI (14)
41.85
Middle of its range
Neutral
MACD
-1.65
Below its signal line
Bearish
Stochastic
32.9
Middle of its range
Neutral
ADX (14)
22.8
Weak trend
Williams %R
-77.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-64.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−28.4%
Change over 10 sessions
Bearish
ATR (14)
$5.55
Typical daily range, 20.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for NBTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how NBTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow NBTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for NBTXHow many large options trades hit NBTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in NBTX in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NBTX is in one of them and how their past NBTX trades turned out.
Nanobiotix is a biotechnology company based in Paris, France, that develops medicines built on nanoparticles. Its lead candidate, JNJ-1900 (NBTXR3), is designed to increase the effect of radiotherapy on tumors while limiting the dose to surrounding healthy tissue, and it is in clinical trials for several cancer types, mainly head and neck and lung cancer. The company also works on earlier stage platforms meant to help other drugs reach target tissues and to treat neurological conditions. Its main partner for the lead candidate is Johnson & Johnson, and the medicines are aimed at people receiving cancer treatment.